NO164095C - Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av 3-(3-substituerte-amino-2-hydroksypropoksy)-4-substituerte-1,2,5-tiadiazolderivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av 3-(3-substituerte-amino-2-hydroksypropoksy)-4-substituerte-1,2,5-tiadiazolderivater.

Info

Publication number
NO164095C
NO164095C NO84843352A NO843352A NO164095C NO 164095 C NO164095 C NO 164095C NO 84843352 A NO84843352 A NO 84843352A NO 843352 A NO843352 A NO 843352A NO 164095 C NO164095 C NO 164095C
Authority
NO
Norway
Prior art keywords
substituted
thiadiazold
hydroxypropoxy
derivatives
amino
Prior art date
Application number
NO84843352A
Other languages
English (en)
Norwegian (no)
Other versions
NO164095B (no
NO843352L (no
Inventor
William L Matier
Paul W Erhardt
Ghanshyam Patil
Original Assignee
American Hospital Supply Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Hospital Supply Corp filed Critical American Hospital Supply Corp
Publication of NO843352L publication Critical patent/NO843352L/no
Publication of NO164095B publication Critical patent/NO164095B/no
Publication of NO164095C publication Critical patent/NO164095C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO84843352A 1982-12-22 1984-08-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av 3-(3-substituerte-amino-2-hydroksypropoksy)-4-substituerte-1,2,5-tiadiazolderivater. NO164095C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/452,280 US4508725A (en) 1982-12-22 1982-12-22 Esters of 3-(3-substituted-amino-2-hydroxypropoxy)-4-substituted-1,2,5-thiadiazole derivatives
PCT/US1983/001847 WO1984002525A1 (fr) 1982-12-22 1983-11-22 Esters de derives de 1,2,5-thiadiazol 3-(3-substitute-amino-2-hydroxypropoxy)-4-substitue

Publications (3)

Publication Number Publication Date
NO843352L NO843352L (no) 1984-08-22
NO164095B NO164095B (no) 1990-05-21
NO164095C true NO164095C (no) 1990-09-05

Family

ID=23795857

Family Applications (1)

Application Number Title Priority Date Filing Date
NO84843352A NO164095C (no) 1982-12-22 1984-08-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av 3-(3-substituerte-amino-2-hydroksypropoksy)-4-substituerte-1,2,5-tiadiazolderivater.

Country Status (14)

Country Link
US (1) US4508725A (fr)
EP (1) EP0131006B1 (fr)
JP (1) JPS60500288A (fr)
AU (1) AU567908B2 (fr)
CA (1) CA1230879A (fr)
DE (1) DE3382578T2 (fr)
ES (1) ES528225A0 (fr)
IE (1) IE59617B1 (fr)
IT (1) IT1172381B (fr)
MX (1) MX156097A (fr)
NO (1) NO164095C (fr)
NZ (1) NZ206385A (fr)
WO (1) WO1984002525A1 (fr)
ZA (1) ZA838829B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623652A (en) 1981-11-12 1986-11-18 American Hospital Supply Corporation Esters of thiadiazole oxypropanolaine derivatives and pharmaceutical uses
US5320839A (en) * 1991-10-11 1994-06-14 Alcon Laboratories, Inc. Topical ophthalmic compositions comprising 4-(3-substituted amino-2-hydroxypropoxy)-1,2,5-thiadiazoles and methods for their use
AU660735B2 (en) * 1991-10-11 1995-07-06 Alcon Laboratories, Inc. Topical ophthalmic compositions comprising 4-(3-substituted amino-2-hydroxypropoxy)-1,2,5-thiadiazoles and methods for their use
US5821370A (en) * 1994-10-24 1998-10-13 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US6750238B1 (en) 2000-05-12 2004-06-15 The University Of Toledo Aralkyl ester soft drugs
US7049326B2 (en) * 2000-05-12 2006-05-23 The University Of Toledo Method and compositions for temporarily incapacitating subjects
US6756047B2 (en) 2000-05-12 2004-06-29 The University Of Toledo Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
US20110092507A1 (en) * 2009-10-20 2011-04-21 Chin-Tsai Fan Process for preparing R-(+)-3-morpholino-4-(3- tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051144A (en) * 1968-05-22 1977-09-27 Charles E. Frosst & Co. Sinister-3,5-disubstituted oxozolidines their preparation and use
US3655663A (en) * 1969-04-21 1972-04-11 Burton K Wasson 4-(3-secondary amino-2-hydroxy-proxy) 1 2 5-thiadiazoles
FR2132570B1 (fr) * 1971-04-09 1974-08-02 Lipha
US3729477A (en) * 1971-09-09 1973-04-24 Frosst & Co Charles E Certain 4-(3-amino-2-hydroxypropoxy)-1,2,5-thiadiazole-3-carboxamides
US4083992A (en) * 1972-12-15 1978-04-11 Imperial Chemical Industries Limited Alkanolamine derivatives
US3891639A (en) * 1973-04-19 1975-06-24 Merck Sharp & Dohme 4-{8 3-Amino-2-acyloxypropoxy{9 -1,2,5-thiadiazole compounds
US4011217A (en) * 1973-04-19 1977-03-08 Merck Sharp & Dohme (I.A.) Corporation 4-(3-amino-2-acyloxypropoxy)-1,2,5-thiadiazole compounds
AT361486B (de) * 1975-08-07 1981-03-10 Hoffmann La Roche Verfahren zur herstellung von neuen imidazo(1,5 -a) (1,4)diazepinverbindungen, ihren salzen und optisch aktiven formen
US4127674A (en) * 1977-03-21 1978-11-28 Allergan Pharmaceuticals, Inc. Method of treatment for glaucoma
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
ZA827646B (en) * 1981-11-12 1983-08-31 American Hospital Supply Corp Esters of aryloxypropanolamine derivatives

Also Published As

Publication number Publication date
IT1172381B (it) 1987-06-18
NO164095B (no) 1990-05-21
IT8349538A0 (it) 1983-12-19
JPS60500288A (ja) 1985-03-07
MX156097A (es) 1988-07-07
EP0131006A4 (fr) 1985-06-06
NZ206385A (en) 1986-08-08
WO1984002525A1 (fr) 1984-07-05
ZA838829B (en) 1985-03-27
IE59617B1 (en) 1994-03-09
EP0131006B1 (fr) 1992-06-10
EP0131006A1 (fr) 1985-01-16
NO843352L (no) 1984-08-22
US4508725A (en) 1985-04-02
AU567908B2 (en) 1987-12-10
DE3382578T2 (de) 1993-03-25
CA1230879A (fr) 1987-12-29
ES8504159A1 (es) 1985-04-16
ES528225A0 (es) 1985-04-16
DE3382578D1 (de) 1992-07-16
IE832730L (en) 1984-06-22
AU2334184A (en) 1984-07-17

Similar Documents

Publication Publication Date Title
NO166232C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(5-aminopentyl)-amino-1-benzazepin-2-on-1-alkansyrer.
NO156785C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO156752C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(1-piperidinylalkyl)-4hpyrido(1,2-a)pyrimidin-4-0n derivater
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO874153D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO155665C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,7,7a-tetrahydro-4h-thieno-(3,2-c)-pyridin-2-on-derivater.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO164095C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av 3-(3-substituerte-amino-2-hydroksypropoksy)-4-substituerte-1,2,5-tiadiazolderivater.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO155842C (no) Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider.
NO163617C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater.
NO811134L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-derivater.
NO874780D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater.
NO160136C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av benzoylfenylpiperidin.
NO163327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydropyridiner.
NO813577L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperdin-derivater.
NO153727C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dekahydrokinolinolderivater.
NO162285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolizinon-derivater.